Abbott, Medtronic to Battle Over Patent

Abbott files lawsuit against Medtronic over Rapid Exchange system

By: Editor

NULL

Abbott has filed a lawsuit against Medtronic for infringing on its patent for the Rapid Exchange system.

The lawsuit comes on the heels of Medtronic’s announcement that it is launching its Endeavor drug-eluting stent and other angioplasty products in the US on the Rapid Exchange delivery system, which it anticipates will increase use of its devices, Medtronic said.

Abbott said its Xience V drug-eluting stent has rapidly become the US market leader. It does not expect Medtronic’s launch of a new delivery system to change market dynamics.

SOURCE: FDA NEWS

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters